Еквадор - испански - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

pharmabrand s.a. ecuador - vildagliptina 50,00 mg / tableta - tabletas - cada tableta contiene: vildagliptina(*) (**) 50,00 mg * se ajustará la cantidad del principio activo de acuerdo a la potencia. ** se incorporará un exceso del 5 % por estabilidad.

Еквадор - испански - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

caritas healthcare private limited india - cada tableta no recubierta contiene: vildagliptina???????50 mg - tableta sin recubrimiento - cada tableta no recubierta contiene: vildagliptina???????50 mg

Европейски съюз - испански - EMA (European Medicines Agency)

novartis europharm limited - vildagliptina - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Европейски съюз - испански - EMA (European Medicines Agency)

novartis europharm limited - vildagliptina - diabetes mellitus, tipo 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

Европейски съюз - испански - EMA (European Medicines Agency)

novartis europharm limited - vildagliptina - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

Перу - испански - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

farmindustria s.a. - droguerÍa - tableta - por tableta - - vildagliptina

Испания - испански - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sandoz farmaceutica s.a. - vildagliptina - comprimido - 50 mg - vildagliptina 50 mg - vildagliptina

Испания - испански - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

krka d.d. novo mesto - vildagliptina - comprimido - 50 mg - vildagliptina 50 mg - vildagliptina

Испания - испански - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

krka d.d. novo mesto - vildagliptina - comprimido - 50 mg - vildagliptina 50 mg - vildagliptina

Испания - испански - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

teva b.v. - vildagliptina - comprimido - 50 mg - vildagliptina 50 mg - vildagliptina